Processing 00000000.tx.1: Genetic association of an [alpha]2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease A. 

Phrase: "Genetic association of an [alpha]2-macroglobulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(Val1000Ile"

Phrase: ")"

Phrase: "polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.2: Liao, R. 

Phrase: "Liao,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Nitsch1, S. 

Phrase: "Nitsch1,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: Greenberg, U. 

Phrase: "Greenberg,"

Phrase: "U."
Processing 00000000.tx.7: Finckh1, D. 

Phrase: "Finckh1,"

Phrase: "D."
Processing 00000000.tx.8: Blacker, M. 

Phrase: "Blacker, M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: Albert, G. 

Phrase: "Albert,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.10: W. 

Phrase: "W."
Processing 00000000.tx.11: Rebeck, T. 

Phrase: "Rebeck,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.12: Gomez-Isla, A. 

Phrase: "Gomez-Isla,"

Phrase: "A."
Processing 00000000.tx.13: Clatworthy, G. 

Phrase: "Clatworthy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.14: Binetti2, C. 

Phrase: "Binetti2,"

Phrase: "C."
Processing 00000000.tx.15: Hock3, T. 

Phrase: "Hock3,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.16: Mueller-Thomsen1, U. 

Phrase: "Mueller-Thomsen1,"

Phrase: "U."
Processing 00000000.tx.17: Mann1, K. 

Phrase: "Mann1,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.18: Zuchowski1, U. 

Phrase: "Zuchowski1,"

Phrase: "U."
Processing 00000000.tx.19: Beisiegel1, H. 

Phrase: "Beisiegel1,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.20: Staehelin3, J. 

Phrase: "Staehelin3,"

Phrase: "J."
Processing 00000000.tx.21: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.22: Growdon, R. 

Phrase: "Growdon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.23: E. 

Phrase: "E."
Processing 00000000.tx.24: Tanzi and B. 

Phrase: "Tanzi"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.25: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.26: Hyman* Alzheimer Research Unit, Neurology Service, Massachusetts General Hospital, 149 13th Street (CNY 6405), Charlestown, MA 02129, USA, 1University of Hamburg, Hamburg, Germany, 2IRCCS, S. 

Phrase: "Hyman"

Phrase: "* Alzheimer Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Neurology Service,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0587591:Neurology service [Therapeutic or Preventive Procedure]
   861   C0557854:Service [Occupational Activity]
   861   C2825316:Service [Manufactured Object]
   861   C3245478:service [Idea or Concept]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "149 13th Street"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "(CNY 6405"

Phrase: ")"

Phrase: ","

Phrase: "Charlestown,"

Phrase: "MA 02129,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "1University of Hamburg,"

Phrase: "Hamburg,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "2IRCCS,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.27: Giovanni de Dio FBF, Brescia, Italy and 3University of Basel, Basel, Switzerland Received July 2, 1998; 

Phrase: "Giovanni de Dio FBF,"

Phrase: "Brescia,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "and"

Phrase: "3University of Basel,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "July 2,"

Phrase: "1998"

Phrase: ";"
Processing 00000000.tx.28: Revised and Accepted August 20, 1998 [alpha]2-Macroglobulin (A2M) is a proteinase inhibitor found in association with senile plaques (SP) in Alzheimer's disease (AD). 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted August 20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998"

Phrase: "[alpha]2-Macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "(A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "a proteinase inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
  1000   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C2673177:proteinase inhibitor [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "found in association"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0150312:Found [Quantitative Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0243095:Find [Finding]

Phrase: "with senile plaques (SP)"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.29: A2M has been implicated biochemically in binding and degradation of the amyloid [beta] (A[beta]) protein which accumulates in SP. 

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "implicated"

Phrase: "biochemically in binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "degradation of the amyloid [beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "]"

Phrase: "(A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: ")"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "accumulates in SP."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0392079:Senile [Finding]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]
Processing 00000000.tx.30: We studied the relationship between Alzheimer's disease and a common A2M polymorphism, Val1000 (GTC)/Ile1000 (ATC), which occurs near the thiolester active site of the molecule. 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the relationship between Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1707789:Disease Relationship [Conceptual Entity]
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "a common A2M polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "Val1000"

Phrase: "(GTC)/Ile1000"

Phrase: "(ATC"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "occurs near the thiolester active site of the molecule."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0205681:Active Site [Functional Concept]
   764   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C0205177:Active [Functional Concept]
   742   C0567416:Molecule [Substance]
   742   C1515974:Site [Body Location or Region]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]
   742   C2825164:Site [Spatial Concept]
   726   C0596968:molecular site [Functional Concept]
Processing 00000000.tx.31: In an initial exploratory data set (90 controls and 171 Alzheimer's disease) we noted an increased frequency of the G/G genotype from 0.07 to 0.12. 

Phrase: "In an initial exploratory data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0150098:Data Set [Intellectual Product]
   861   C1706233:Dataset [Intellectual Product]
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1511726:Data [Idea or Concept]
   812   C1705195:Set [Conceptual Entity]
   812   C3245479:data [Medical Device]

Phrase: "(90 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "171 Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "an increased frequency of the G/G genotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "from 0.07"

Phrase: "to 0.12."
Processing 00000000.tx.32: We therefore tested the hypothesis that the G/G genotype is over-represented in Alzheimer's disease in an additional independent data set: a group of 359 controls and 566 Alzheimer's disease patients. 

Phrase: "We therefore"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "is"

Phrase: "over-represented in Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205136:Over [Spatial Concept]
   726   C1882932:Represent [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "in an additional independent data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0150098:Data Set [Intellectual Product]
   861   C1706233:Dataset [Intellectual Product]
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1511726:Data [Idea or Concept]
   812   C1705195:Set [Conceptual Entity]
   812   C3245479:data [Medical Device]

Phrase: ":"

Phrase: "a group of 359 controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0441835:a group [Classification]
   781   C0009932:Control Group [Group]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "566 Alzheimer's disease patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.33: In the hypothesis testing cohort, the G/G genotype increased from 0.07 in controls to 0.12 in Alzheimer's disease (P < 0.05, Fisher's exact test). 

Phrase: "In the hypothesis testing cohort,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0599755:Cohort [Population Group]
   734   C0681918:hypothesis testing [Research Activity]
   717 E C0237913:Hypothesis Test [Intellectual Product]

Phrase: "the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "increased from 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "to 0.12"

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fisher's exact test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0325045:Fisher [Mammal]
   827   C0392366:test [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.34: The odds ratio for Alzheimer's disease associated with the G/G genotype was 1.77 (1.16-2.70, P < 0.01) and in combination with APOE4 was 9.68 (95% CI 3.91-24.0, P < 0.001). 

Phrase: "The odds ratio for Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "associated with the G/G genotype"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1319635:g/g [Quantitative Concept]
   753   C0017431:Genotype [Organism Attribute]
   753   C0439267:g% [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "1.77"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(1.16-2.70,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0580272:1/2 [Intellectual Product]
   875   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and in combination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205195:Combination [Qualitative Concept]
   790   C1515981:And [Idea or Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with APOE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "was"

Phrase: "9.68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "(95% CI 3.91-24.0,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.35: The presence of the G allele was associated with an increase in A[beta] burden in a small series. 

Phrase: "The presence of the G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: "burden in a small series."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205549:Series [Quantitative Concept]
   760   C0700321:Small [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]
   760   C2828008:Burden [Idea or Concept]
Processing 00000000.tx.36: The A2M receptor, A2M-r/LRP, is a multifunctional receptor whose ligands include apolipoprotein E and the amyloid precursor protein. 

Phrase: "The A2M receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "A2M-r/LRP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C1412046:A2M gene [Gene or Genome]
   877   C0079423:R Gene [Gene or Genome]
   845   C1335671:Receptor Gene [Gene or Genome]
   818   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0017337:Gene [Gene or Genome]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "is"

Phrase: "a multifunctional receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "whose ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the amyloid precursor protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.37: These four proteins have each been genetically linked to Alzheimer's disease, suggesting that they may participate in a common disease pathway. 

Phrase: "These four proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "each"

Phrase: "been"

Phrase: "genetically"

Phrase: "linked to Alzheimer's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "may"

Phrase: "participate in a common disease pathway."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1511986:Disease Pathway [Conceptual Entity]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C3245511:common [Intellectual Product]
Processing 00000000.tx.38: INTRODUCTION [alpha]2-Macroglobulin (A2M) is a proteinase inhibitor which inhibits proteinases of all classes by a steric trapping mechanism. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "[alpha]2-Macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "(A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "a proteinase inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
  1000   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C2673177:proteinase inhibitor [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteinases of all classes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   737 E C1622131:proteinase [Molecular Function]
   737 E C1947941:Proteinase [Enzyme]

Phrase: "by a steric trapping mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.39: The tetrameric A2M structure undergoes a conformational change upon cleavage of a peptide bond in the bait region by a proteinase and this conformational change traps the proteinase. 

Phrase: "The tetrameric A2M structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "undergoes"

Phrase: "a conformational change upon cleavage of a peptide bond"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0301641:Conformational change [Molecular Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "in the bait region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "by a proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "this conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0301641:Conformational change [Molecular Function]
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "traps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:trap [Medical Device]

Phrase: "the proteinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.40: A2M has been implicated in several pathophysiological processes in Alzheimer's disease. 

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in several pathophysiological processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.41: A2M immunostains senile plaques (SP) (1-3) and binds amyloid [beta] protein (A[beta]) 1-42 with high affinity (apparent Kd < 1.0 nM) (4). 

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "immunostains"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "(SP"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: ")"

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "amyloid [beta] protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: ")"

Phrase: "1-42 with high affinity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]

Phrase: "(apparent Kd < 1.0 nM) (4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0026691:KD [Disease or Syndrome]
   799   C0312860:NM [Cell Function]
   799   C0750489:apparent [Idea or Concept]
   799   C1705240:KD [Gene or Genome]
   799   C1839259:KD [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.42: Moreover, recent data suggest that a serine proteinase-A2M complex can degrade A[beta] (5) and trypsin-activated A2M efficiently degrades A[beta] in vitro and prevents in vitro formation of thioflavin S-positive A[beta] fibrils as well as A[beta]-induced toxicity of cultured human cortical neuronal cells (6). 

Phrase: "Moreover,"

Phrase: "recent data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a serine proteinase-A2M complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "can"

Phrase: "degrade"

Phrase: "A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "trypsin-activated A2M efficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412046:A2M [Gene or Genome]

Phrase: "degrades"

Phrase: "A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "] in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "in vitro formation of thioflavin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "S-"

Phrase: "positive A[beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "] fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "as well as"

Phrase: "A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]-induced toxicity of cultured human cortical neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040539:toxicity [Qualitative Concept]
   744   C0600688:Toxicity [Injury or Poisoning]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.43: After being activated, A2M is cleared by the A2M-r/low density lipoprotein receptor-related protein (A2M-r/LRP). 

Phrase: "After"

Phrase: "being"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "is"

Phrase: "cleared by the A2M-r/low density lipoprotein receptor-related protein"
Meta Candidates (Total=27; Excluded=2; Pruned=0; Remaining=25)
   797   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   797   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   775   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   756   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0521097:Cleared by [Functional Concept]
           cleared
   754   C0168981:protein r [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0242972:low protein [Therapeutic or Preventive Procedure]
   754   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   754   C0599283:receptor density [Genetic Function]
   754   C0748025:low protein [Finding]
   738   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0178587:density [Quantitative Concept]
   738   C0205090:R- [Spatial Concept]
   738   C0205251:low [Qualitative Concept]
   738   C0439849:Related [Qualitative Concept]
   738   C0445223:Related [Finding]
   738   C0684010:R. [Professional or Occupational Group]
   738   C1299352:Low [Qualitative Concept]
   738   C1412046:A2M [Gene or Genome]
   738   C1550472:low [Idea or Concept]
   738   C2603358:R' [Clinical Attribute]
   704 E C0163712:Relate [Organic Chemical]
   704 E C2963144:Clear [Qualitative Concept]

Phrase: "(A2M-r/LRP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C1412046:A2M gene [Gene or Genome]
   877   C0079423:R Gene [Gene or Genome]
   845   C1335671:Receptor Gene [Gene or Genome]
   818   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0017337:Gene [Gene or Genome]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.44: A2M-r/LRP is a multifunctional receptor and interestingly is also the primary neuronal apolipoprotein E (apoE) receptor (7,8). 

Phrase: "A2M-r/LRP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C1412046:A2M gene [Gene or Genome]
   877   C0079423:R Gene [Gene or Genome]
   845   C1335671:Receptor Gene [Gene or Genome]
   818   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0017337:Gene [Gene or Genome]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "is"

Phrase: "a multifunctional receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "interestingly"

Phrase: "is"

Phrase: "also"

Phrase: "the primary neuronal apolipoprotein E (apoE) receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0051300:Receptor, Apolipoprotein E [Amino Acid, Peptide, or Protein,Receptor]
   884   C1416912:APOLIPOPROTEIN E RECEPTOR [Gene or Genome]
           APOLIPOPROTEIN RECEPTOR
   884   C2987172:Apolipoprotein E Receptor [Amino Acid, Peptide, or Protein]
   875   C2325760:Neuronal receptor [Cell Component]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.45: LRP also binds and clears the Kunitz proteinase inhibitor containing isoforms of the amyloid precursor protein (APP) (9). 

Phrase: "LRP also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1335671:Receptor Gene [Gene or Genome]
   827   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017337:Gene [Gene or Genome]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "clears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "the Kunitz proteinase inhibitor containing isoforms of the amyloid precursor protein (APP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.46: Thus A2M potentially impacts both apoE and APP metabolism in the brain. 

Phrase: "Thus A2M potentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412046:A2M [Gene or Genome]

Phrase: "impacts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "both apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "APP metabolism in the brain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1327340:amyloid precursor protein metabolism [Molecular Function]
   778   C0597299:Protein Metabolism [Molecular Function]
   774   C0596215:brain metabolism [Organ or Tissue Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.47: Because of these biological links to Alzheimer's disease, we studied the possible association of a previously reported polymorphism in the A2M gene with Alzheimer's disease. 

Phrase: "Because of these biological links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "to Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the possible association of a previously reported polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "in the A2M gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412046:A2M gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.48: Poller et al. 

Phrase: "Poller et al."
Processing 00000000.tx.49: (10) screened 30 normal and 30 pulmonary disease patients for A2M polymorphisms at or near the active site and reported three A2M polymorphisms. 

Phrase: "(10"

Phrase: ")"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "30 normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "30 pulmonary disease patients for A2M polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "at"

Phrase: "or near the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0205681:Active Site [Functional Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "reported three A2M polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.50: The most common occurred 25 amino acids downstream from the thiolester site, interchanging Val1000 (GTC) and Ile1000 (ATC) (10). 

Phrase: "The most common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "25 amino acids downstream from the thiolester site,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "interchanging"

Phrase: "Val1000"

Phrase: "(GTC)"

Phrase: "and"

Phrase: "Ile1000"

Phrase: "(ATC) (10"

Phrase: ")."
Processing 00000000.tx.51: (Numbering is based on the cDNA sequence which includes a 24 amino acid signal peptide; this corresponds to Val/Ile976 in the mature protein.) 

Phrase: "(Numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "based on the cDNA sequence"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   781   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a 24 amino acid signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0037081:Signal Peptide [Amino Acid Sequence]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: ";"

Phrase: "this"

Phrase: "corresponds to Val/Ile976"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in the mature protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"
Processing 00000000.tx.52: Allele frequencies in their 60 probands were 0.3 (GTC) and 0.7 (ATC). 

Phrase: "Allele frequencies in their 60 probands"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:Frequencies, Allele [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "0.3"

Phrase: "(GTC)"

Phrase: "and"

Phrase: "0.7"

Phrase: "(ATC"

Phrase: ")."
Processing 00000000.tx.53: No difference in A2M serum levels was associated with the two alleles. 

Phrase: "No difference in A2M serum levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "associated with the two alleles."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0002085:Alleles [Gene or Genome]
   760   C0205448:Two [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.54: This polymorphism is especially interesting because it has the potential to be biologically relevant to the function of A2M as a proteinase inhibitor because it occurs near the thiolester active site of the molecule. 

Phrase: "This polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "especially"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "because"

Phrase: "it"

Phrase: "has"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "be"

Phrase: "biologically relevant to the function of A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]

Phrase: "as a proteinase inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
  1000   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C2673177:proteinase inhibitor [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "occurs near the thiolester active site of the molecule."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0205681:Active Site [Functional Concept]
   764   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C0205177:Active [Functional Concept]
   742   C0567416:Molecule [Substance]
   742   C1515974:Site [Body Location or Region]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]
   742   C2825164:Site [Spatial Concept]
   726   C0596968:molecular site [Functional Concept]
Processing 00000000.tx.55: RESULTS Our initial exploratory experiment tested the possibility that the less common form of A2M (the `G' allele) would be associated with Alzheimer's disease. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "Our initial exploratory experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the less common form of A2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "the `G' allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "would"

Phrase: "be"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.56: Because of the potential for error due to multiple hypothesis testing, we planned to use the initial data set as an exploratory data set, with the intent to formulate specific hypotheses which would then be tested formally in a second independent data set. 

Phrase: "Because of the potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]

Phrase: "for error"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0743559:error [Qualitative Concept]
  1000   C1608199:Error [Functional Concept]

Phrase: "due to multiple hypothesis testing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0681918:hypothesis testing [Research Activity]
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]

Phrase: "we"

Phrase: "planned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1301732:Planned [Functional Concept]
   966 E C0270724:PLAN [Disease or Syndrome]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the initial data set as an exploratory data set,"

Phrase: "with the intent to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0162425:intent [Mental Process]
   861   C1283828:intent [Qualitative Concept]
   861   C1550453:intent [Idea or Concept]

Phrase: "formulate"

Phrase: "specific hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "which"

Phrase: "would"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "formally in a second independent data set."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0150098:Data Set [Intellectual Product]
   778   C1706233:Dataset [Intellectual Product]
   748   C0036849:Set [Mental Process]
   748   C0085862:Independent [Idea or Concept]
   748   C0205436:Second [Quantitative Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C1299583:Independent [Finding]
   748   C1442518:Set [Functional Concept]
   748   C1511726:Data [Idea or Concept]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C1705195:Set [Conceptual Entity]
   748   C3245479:data [Medical Device]
Processing 00000000.tx.57: We genotyped 90 non-Alzheimer's individuals who had either undergone screening tests with the Blessed dementia scale (11) or whose DNA had been isolated from autopsy material and were demonstrated to not have Alzheimer's disease and 171 individuals who either had a clinical diagnosis of Alzheimer's disease or neuropathologically proven Alzheimer's disease (Table 1). 

Phrase: "We"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "90 non-Alzheimer's individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "who"

Phrase: "had"

Phrase: "either undergone screening tests with the Blessed dementia scale"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C0871311:Screening Tests [Health Care Activity]
   762   C0438925:dementia tests [Diagnostic Procedure]
   745   C0392757:test scale [Educational Activity]
   742   C0022885:Tests [Laboratory Procedure]
   742   C0220908:Screening [Health Care Activity]
   742   C0220909:screening [Functional Concept]
   742   C0392366:Tests [Intellectual Product]
   742   C1698960:screening [Intellectual Product]
   742   C1710031:Screening [Diagnostic Procedure]
   742   C1710477:SCREENING [Research Activity]
   708 E C0039593:Test [Functional Concept]
   708 E C1305399:screen [Functional Concept]
   708 E C1705053:Screen [Medical Device]

Phrase: "(11"

Phrase: ")"

Phrase: "or"

Phrase: "whose DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "been"

Phrase: "isolated from autopsy material"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0004398:Autopsy [Diagnostic Procedure]
   770   C0205409:Isolated [Functional Concept]
   770   C0520510:Material [Substance]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "171 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "who either"

Phrase: "had"

Phrase: "a clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332140:Diagnosis, clinical [Qualitative Concept]
   753   C0011900:Diagnosis [Finding]
   753   C0205210:Clinical [Qualitative Concept]
   753   C1704338:diagnosis [Qualitative Concept]
   753   C1704656:DIAGNOSIS [Research Activity]

Phrase: "or"

Phrase: "neuropathologically proven Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.58: Genotypes were determined by PCR amplification of DNA and restriction enzyme digestion (Fig. 1). 

Phrase: "Genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "determined by PCR amplification of DNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0683230:DNA amplification [Genetic Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "restriction enzyme digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0012238:Digestion [Organism Function]
   827   C2349986:Digestion [Research Activity]
   771 E C0443277:Peptic [Functional Concept]
   734   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.59: In our control series, the G allele frequency was 0.28 and six of 90 individuals contained the G/G genotype (0.067). 

Phrase: "In our control series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "the G allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "0.28"

Phrase: "and"

Phrase: "six of 90 individuals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205452:Six [Quantitative Concept]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "(0.067"

Phrase: ")."
Processing 00000000.tx.60: In the Alzheimer's disease set, the G allele frequency was 0.32. 

Phrase: "In the Alzheimer's disease set,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "the G allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "0.32."
Processing 00000000.tx.61: We noticed that the G/G genotype frequency was increased in the Alzheimer's group at 0.12 (Table 1). 

Phrase: "We"

Phrase: "noticed"

Phrase: "that"

Phrase: "the G/G genotype frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "increased in the Alzheimer's group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205217:Increased [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "at 0.12"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.62: These results suggest a possible influence of this A2M polymorphism as a genetic risk factor for Alzheimer's disease. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a possible influence of this A2M polymorphism"

Phrase: "as a genetic risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   734   C1517512:Genetic Risk [Quantitative Concept]

Phrase: "for Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.63: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.64: Electrophoresis pattern of restriction digest demonstrating bands representing the G (532 bp) and the A alleles (429 bp). 

Phrase: "Electrophoresis pattern of restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "demonstrating"

Phrase: "bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the G (532 bp)"

Phrase: "and"

Phrase: "the A alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "(429 bp"

Phrase: ")."
Processing 00000000.tx.65: Table 1. 

Phrase: "Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.66: Over-representation of the A2M G/G genotype in Alzheimer's disease  n G allele (%) G/G genotype (%) Exploratory data set Control 90 0.28 0.07 AD 171 0.32 0.12 Hypothesis testing data set Control 359 0.32 0.07 AD 566 0.34 0.12a Combined data set (total) Control 449 0.32 0.07 AD 737 0.34 0.12b aP < 0.05; 

Phrase: "Over-representation of the A2M G/G genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205136:Over [Spatial Concept]
   744   C1514861:Representation [Conceptual Entity]
   744   C1882932:Representation [Activity]

Phrase: "in Alzheimer's disease  n G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Allele [Gene or Genome]

Phrase: "(%"

Phrase: ")"

Phrase: "G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "(%"

Phrase: ")"

Phrase: "Exploratory data set Control 90 0.28 0.07 AD 171 0.32 0.12 Hypothesis testing data set Control 359 0.32 0.07 AD 566 0.34 0.12a Combined data set"

Phrase: "(total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "Control 449 0.32 0.07 AD 737 0.34 0.12b aP < 0.05"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   785   C0243148:control [Qualitative Concept]
   785   C1550141:Control [Substance]
   785   C1882979:Control [Conceptual Entity]
   785   C2587213:Control [Functional Concept]
   785   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.67: bP < 0.01. 

Phrase: "bP < 0.01."
Processing 00000000.tx.68: To formally test the hypothesis that the G/G genotype of A2M is over-represented in Alzheimer's disease, we collected and genotyped additional independent groups of patients and controls. 

Phrase: "To formally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the G/G genotype of A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotype [Organism Attribute]

Phrase: "is"

Phrase: "over-represented in Alzheimer's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205136:Over [Spatial Concept]
   726   C1882932:Represent [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "additional independent groups of patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.69: Power analysis showed that >500 Alzheimer's disease and control individuals would be necessary to have an 80% chance of showing a difference between genotype frequencies of 0.07 and 0.12. 

Phrase: "Power analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: ">500 Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "would"

Phrase: "be"

Phrase: "necessary to"

Phrase: "have"

Phrase: "an 80% chance of showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0237506:Chance [Qualitative Concept]

Phrase: "a difference between genotype frequencies of 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "0.12."
Processing 00000000.tx.70: We therefore collected cases and controls from several sites in order to approximate this number of samples. 

Phrase: "We therefore collected cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls from several sites"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205145:Sites [Spatial Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "in order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to approximate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximate [Qualitative Concept]

Phrase: "this number of samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.71: The second data set consisted of individuals who met the same criteria for Alzheimer's disease or control as the hypothesis generating set and were derived from sporadic Alzheimer's disease patients in Massachusetts, from three European centers and from probands of a multicenter US study of sib pairs and small families. 

Phrase: "The second data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0150098:Data Set [Intellectual Product]
   901   C1706233:Dataset [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "consisted of individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "who"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the same criteria for Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]

Phrase: "or"

Phrase: "control as the hypothesis generating set"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "derived from sporadic Alzheimer's disease patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0205422:Sporadic [Temporal Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "in Massachusetts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024874:Massachusetts [Geographic Area]

Phrase: "from three European centers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:centers [Spatial Concept]

Phrase: "and from probands of a multicenter"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0702111:probands [Organism Attribute]
   753   C1515981:And [Idea or Concept]
   719 E C1948021:Proband [Family Group]

Phrase: "US"

Phrase: "study of sib pairs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037047:Sib [Family Group]
   770   C0557651:Study [Manufactured Object]
   770   C1709450:Pair [Qualitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "small families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.72: The results from the second data set supported the hypothesis, with G/G genotype frequencies of 0.07 in controls and 0.12 in Alzheimer's disease (P < 0.05, Fisher's exact test) (Table 1). 

Phrase: "The results from the second data set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "the hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "with G/G genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0439603:Frequencies [Temporal Concept]
   779 E C0376249:frequency [Quantitative Concept]
   779 E C0871396:Frequency [Quantitative Concept]
   779 E C1561548:Frequency [Qualitative Concept]
   779 E C1705502:Frequency [Quantitative Concept]
   729 E C0332183:Frequent [Temporal Concept]

Phrase: "of 0.07"

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "0.12 in Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   844   C1970209:Alzheimer Disease 12 [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fisher's exact test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0325045:Fisher [Mammal]
   827   C0392366:test [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: The G allele was not over-represented in this data set (control = 0.32; Alzheimer's disease = 0.34). 

Phrase: "The G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "over-represented in this data set"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0150098:Data Set [Intellectual Product]
   790   C1706233:Dataset [Intellectual Product]
   753   C0036849:Set [Mental Process]
   753   C0205136:Over [Spatial Concept]
   753   C1442518:Set [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]
   719   C1882932:Represent [Activity]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "= 0.32"

Phrase: "; Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "= 0.34"

Phrase: ")."
Processing 00000000.tx.74: No difference in age of onset between G/G and non-G/G was found in the second data set. 

Phrase: "No difference in age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0699810:age difference [Age Group]
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between G/G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "and"

Phrase: "non-G/G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1319635:g/g [Quantitative Concept]

Phrase: "was"

Phrase: "found in the second data set."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0150098:Data Set [Intellectual Product]
   790   C1706233:Dataset [Intellectual Product]
   783   C1553409:Data found [Idea or Concept]
   753   C0036849:Set [Mental Process]
   753   C0150312:Found [Quantitative Concept]
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1442518:Set [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]
   719 E C0243095:Find [Finding]
Processing 00000000.tx.75: Multivariate analysis showed that site of collection did not influence genotype frequencies. 

Phrase: "Multivariate analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026777:Multivariate Analysis [Quantitative Concept]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that site of collection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "genotype frequencies."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.76: We also compared the rate in controls to the subset of 387 clinic-based Alzheimer's disease cases (G/G frequency = 11.4%, P = 0.06) and the subset of 179 familial Alzheimer's disease samples (G/G frequency = 12.7%, P = 0.056) and found essentially equal over-representation of G/G in each. 

Phrase: "We also"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the rate in controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0489879:Rate control [Functional Concept]
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "to the subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of 387 clinic-based Alzheimer's disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "(G/G frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "= 11.4%,"

Phrase: "P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "the subset of 179 familial Alzheimer's disease samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1515021:Subset [Classification]

Phrase: "(G/G frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "= 12.7%,"

Phrase: "P = 0.056"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "essentially equal over-representation of G/G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "in each."
Processing 00000000.tx.77: These data support an association of the G/G genotype with Alzheimer's disease. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an association of the G/G genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.78: We then carried out a series of exploratory analyses using pooled data from all individuals (737 Alzheimer's disease patients and 449 controls). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a series of exploratory analyses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pooled data from all individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "(737 Alzheimer's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "449 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.79: The G/G genotype was present in 11.9% of the Alzheimer patients and 7.3% of the controls (P < 0.01, Fisher's exact test). 

Phrase: "The G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "was"

Phrase: "present in 11.9% of the Alzheimer patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "7.3% of the controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fisher's exact test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0325045:Fisher [Mammal]
   827   C0392366:test [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.80: The genotype frequency in controls was consistent with a Hardy-Weinberg equilibrium. 

Phrase: "The genotype frequency in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "consistent with a Hardy-Weinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.81: Age of onset was not different between Alzheimer's disease patients with G/G (70.0  9.2, mean  SD) and non-G/G carriers (70.6  9.1). 

Phrase: "Age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "not different between Alzheimer's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "with G/G (70.0  9.2,"

Phrase: "mean  SD)"

Phrase: "and"

Phrase: "non-G/G carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0007294:carriers [Finding]
   779 E C0560175:Carrier [Finding]
   779 E C1706209:Carrier [Medical Device]
   779 E C3273162:Carrier [Intellectual Product]

Phrase: "(70.6  9.1"

Phrase: ")."
Processing 00000000.tx.82: A multivariate logistic model that controlled for the presence of the APOE4 allele and gender showed an odds ratio of 1.88 (95% CI 1.20-2.95, P < 0.01) for the presence of A2M G/G genotype. 

Phrase: "A multivariate logistic model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   827   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "controlled for the presence of the APOE4 allele"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C3642141:APOE*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]
   744   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C2587213:Controlled [Functional Concept]
   744   C2984964:APOE4 [Laboratory Procedure]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an odds ratio of 1.88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "(95% CI 1.20-2.95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   839   C1417650:CI-20 [Gene or Genome]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A2M G/G genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.83: The presence of APOE4 in this model was associated with an odds ratio of 4.21 (95% CI 3.20-5.55, P < 0.001). 

Phrase: "The presence of APOE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "associated with an odds ratio of 4.21"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0028873:Odds Ratio [Quantitative Concept]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(95% CI 3.20-5.55,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1417650:CI-20 [Gene or Genome]
   799   C0450382:55 [Intellectual Product]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.84: The odds ratio of the combination of G/G and APOE4 is 9.68 (95% CI 3.91-24.0, P < 0.001) relative to those with neither risk factor. 

Phrase: "The odds ratio of the combination of G/G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0028873:Odds Ratio [Quantitative Concept]
   762   C0201837:g ratio [Laboratory Procedure]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "APOE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "is"

Phrase: "9.68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "(95% CI 3.91-24.0,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "relative to those with neither risk factor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0242492:Relative Risk [Quantitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.85: To explore whether the G/G-mediated risk was influenced by the presence or absence of APOE4, we stratified the sample by the presence or absence of APOE4. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "whether"

Phrase: "the G/G-mediated risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035647:Risk [Qualitative Concept]

Phrase: "was"

Phrase: "influenced by the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of APOE4,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "we"

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "the sample by the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "absence of APOE4."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.86: Similar over-representations of the G/G genotype were seen in the strata with or without APOE4, suggesting that the effects of the two risk factors are independent. 

Phrase: "Similar over-representations of the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1514861:Representation [Conceptual Entity]
   711   C1882932:Representation [Activity]

Phrase: "were"

Phrase: "seen in the strata"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "with"

Phrase: "or without APOE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effects of the two risk factors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "independent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085862:Independent [Idea or Concept]
  1000   C1299583:Independent [Finding]
Processing 00000000.tx.87: Multivariate analysis for interaction between the G/G genotype and either APOE4 or gender demonstrated no interactions (P > 0.5 for interaction terms). 

Phrase: "Multivariate analysis for interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0026777:Multivariate Analysis [Quantitative Concept]
   819   C0237688:Interaction Analysis [Quantitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "between the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "and"

Phrase: "either APOE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "or"

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "demonstrated"

Phrase: "no interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "(P > 0.5 for interaction terms"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1704675:Interaction [Functional Concept]
   753   C2603361:P' [Clinical Attribute]
   719   C1515273:Term [Temporal Concept]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: Analysis based on the Mantel-Haenszel estimator suggested no heterogeneity of odds ratios between strata with and without APOE4 (P > 0.5), consistent with the absence of an interaction between A2M and APOE4 in our logistic regression model. 

Phrase: "Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "based on the Mantel-Haenszel estimator"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0401805:Estimator [Professional or Occupational Group]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "no heterogeneity of odds ratios"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "between strata"

Phrase: "with"

Phrase: "and without APOE4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C1515981:And [Idea or Concept]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(P > 0.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0444499:0/5 [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "consistent with the absence of an interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "between A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "and"

Phrase: "APOE4 in our logistic regression model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   753   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.89: We next turned our attention to possible biological effects of inheritance of the A2M G/G genotype. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "our attention to possible biological effects of inheritance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0004268:Attention [Mental Process]

Phrase: "of the A2M G/G genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.90: Our previous studies of A2M immunohistochemistry in Alzheimer brain suggested that SP in different cases stained with varying intensity (3). 

Phrase: "Our previous studies of A2M immunohistochemistry"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "in Alzheimer brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that SP in different cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   753   C0392079:Senile [Finding]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "stained with varying intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0522510:Intensity [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.91: We explored the possibility that this variability was due to different genotypes by immunostaining eight Alzheimer's disease cases known to be G/G or A/A genotype. 

Phrase: "We"

Phrase: "explored"

Phrase: "the possibility"

Phrase: "that"

Phrase: "this variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "was due to different genotypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0017431:Genotypes [Organism Attribute]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1705242:Different [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "by immunostaining eight Alzheimer's disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "G/G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "or"

Phrase: "A/"

Phrase: "A genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.92: In all instances, A2M immunoreactivity was present robustly on SP, astrocytes and neurons and no qualitative differences were observed between the genotype groups. 

Phrase: "In all instances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550608:Instance [Idea or Concept]

Phrase: "A2M immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "present robustly on SP,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   760   C0150312:Present [Quantitative Concept]
   760   C0392079:Senile [Finding]
   760   C0449450:Present [Idea or Concept]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "no qualitative differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed between the genotype groups."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0017431:Genotype [Organism Attribute]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1441672:Observed [Functional Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.93: We also explored what effect inheritance of the A2M G/G genotype had on the neuropathological phenotype of Alzheimer's disease (Table 2). 

Phrase: "We also"

Phrase: "explored"

Phrase: "what effect inheritance of the A2M G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0242538:Inheritance [Quantitative Concept]
   742   C0728826:Inheritance [Functional Concept]

Phrase: "had on the neuropathological phenotype of Alzheimer's disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0031437:Phenotype [Organism Attribute]
   744   C0062074:HAD [Therapeutic or Preventive Procedure]
   744   C1285572:Phenotype [Laboratory Procedure]
   744   C1415458:HAD [Gene or Genome]
   744   C3539897:Had [Qualitative Concept]
   731   C1540677:neuropathology disease [Pathologic Function]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: We have previously used stereological techniques and quantitative image analysis to measure the amount of A[beta] present (amyloid burden) in the neocortical association area surrounding the superior temporal sulcus and the number of neurofibrillary tangles present in the same region (12). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "stereological techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "and"

Phrase: "quantitative image analysis to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0200767:Image analysis, quantitative [Laboratory Procedure]
   861   C0200765:Image analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   812   C1704254:Image [Intellectual Product]
   812   C1704922:Image [Entity]
   812   C3542466:Image [Intellectual Product]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the amount of A[beta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "] present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "(amyloid burden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828008:Burden [Idea or Concept]

Phrase: ")"

Phrase: "in the neocortical association area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the superior temporal sulcus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0228237:Superior temporal sulcus [Body Space or Junction]
  1000   C1281074:Superior temporal sulcus [Body Space or Junction]
   901   C0459389:Temporal sulcus [Body Part, Organ, or Organ Component]
   827   C0442043:Temporal [Spatial Concept]
   827   C1184482:Sulcus [Body Space or Junction]
   827   C1282910:Superior [Spatial Concept]
   827   C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the number of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "present in the same region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0150312:Present [Quantitative Concept]
   760   C0205147:Region [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.95: Thirty one of these previously analyzed Alzheimer's disease cases were A2M genotyped and selected for further analysis. 

Phrase: "Thirty one of these previously analyzed Alzheimer's disease cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0205447:One [Quantitative Concept]
   742   C0868928:Cases [Functional Concept]
   742   C0936012:Analyzed [Research Activity]
   742   C1533148:Cases [Quantitative Concept]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "selected for further analysis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C0205108:far [Spatial Concept]
   737   C1707391:Select [Activity]
Processing 00000000.tx.96: Initial inspection of the data suggested an increase in A[beta] in individuals who were A/G or G/G, with no difference between these two groups. 

Phrase: "Initial inspection of the data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0199219:Inspection [Functional Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an increase in A[beta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "]"

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "who"

Phrase: "were"

Phrase: "A/G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "G/G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "with no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "between these two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.97: A statistically significant increase in A[beta] deposition was seen when comparing the G-containing cases with the non-G-containing cases (8.8  2.8 versus 6.6  1.9%, P < 0.03, unpaired t-test). 

Phrase: "A statistically significant increase in A[beta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "] deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "the G-containing cases with the non-G-containing cases"

Phrase: "(8.8  2.8"

Phrase: "versus"

Phrase: "6.6  1.9%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0442751:6 9 [Finding]
   861   C0442750:6/6 [Finding]

Phrase: "P < 0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "unpaired t-test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1710574:Unpaired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: The effect appears to be primarily due to the presence of at least one G allele, in that no difference between A/G and G/G genotypes was observed, although our sample size limits the power of this comparison. 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "primarily due to the presence of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C3146286:Due [Idea or Concept]

Phrase: "at least one G allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "in"

Phrase: "that"

Phrase: "no difference between A/G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "G/G genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "although"

Phrase: "our sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sample Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the power of this comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032863:Power [Human-caused Phenomenon or Process]
Processing 00000000.tx.99: There were no statistically significant differences in neurofibrillary tangle number with G alleles, suggesting a specific effect on A[beta] deposition. 

Phrase: "There"

Phrase: "were"

Phrase: "no statistically significant differences in neurofibrillary tangle number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "with G alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a specific effect on A[beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "] deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.100: Table 2. 

Phrase: "Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.101: Neuropathological correlates of the A2M genotype Genotype n Amyloid burden (%) Neurofibrillary tangles (103) A/A 10 6.6  1.9a 6.9  4.2 A/G + G/G 21 8.8  2.8b 9.0  5.0c aMean  SD. 

Phrase: "Neuropathological correlates of the A2M genotype Genotype n Amyloid burden"

Phrase: "(%"

Phrase: ")"

Phrase: "Neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(103"

Phrase: ")"

Phrase: "A/A 10 6.6  1.9a 6.9  4.2 A/G + G/G 21 8.8  2.8b 9.0  5.0c aMean  SD."
Processing 00000000.tx.102: bP < 0.03, t-test. cn = 17 for this measurement. 

Phrase: "bP < 0.03,"

Phrase: "t-test. cn = 17 for this measurement."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0871472:t-Test [Intellectual Product]
   774   C0695448:measurement test [Diagnostic Procedure]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0242485:Measurement [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.103: DISCUSSION Exploratory studies of genetic risk factors run the risk of type I errors because of the large number of hypotheses that are either explicitly or implicitly being tested. 

Phrase: "DISCUSSION Exploratory studies of genetic risk factors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   757   C2827447:Genetic Study [Research Activity]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "the risk of type I errors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "because of the large number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "either explicitly"

Phrase: "or"

Phrase: "implicitly"

Phrase: "being"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.104: Alternatively, type II errors can occur if sample size is insufficient. 

Phrase: "Alternatively,"

Phrase: "type II errors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0441730:Type II [Classification]
   827   C0332307:Type [Qualitative Concept]
   827   C0743559:errors [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
   793 E C1608199:Error [Functional Concept]

Phrase: "can"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "if"

Phrase: "sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sample Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "insufficient."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205412:Insufficient [Qualitative Concept]
  1000   C0231180:Insufficient [Qualitative Concept]
   928 E C0231179:Insufficiency [Functional Concept]
Processing 00000000.tx.105: In order to overcome some of the difficulties inherent in exploratory studies of genetic risk factors we used independent data sets to first generate, then test the hypothesis that the G/G genotype is associated with Alzheimer's disease. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "some of the difficulties"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C1299586:difficulties [Finding]
   770   C3540770:Some [Intellectual Product]

Phrase: "inherent in exploratory studies of genetic risk factors"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "independent data sets to first"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0150098:data sets [Intellectual Product]
   804   C0036849:Set [Mental Process]
   804   C0085862:Independent [Idea or Concept]
   804   C0205435:First [Quantitative Concept]
   804   C1279901:First [Qualitative Concept]
   804   C1299583:Independent [Finding]
   804   C1442518:Set [Functional Concept]
   804   C1511726:Data [Idea or Concept]
   804   C1705195:Set [Conceptual Entity]
   804   C3245479:data [Medical Device]

Phrase: "generate"

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "is"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.106: Two separate control populations gave identical genotype frequencies; 

Phrase: "Two separate control populations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0032662:control population [Occupation or Discipline]
   812   C0032659:Population [Quantitative Concept]
   812   C0243148:control [Qualitative Concept]
   812   C1257890:Population [Population Group]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "identical genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.107: our hypothesis testing data set was itself made up of two groups (sporadic AD and probands from a multicenter study of Alzheimer's disease sib pairs and small families) each of which gave essentially identical genotype frequencies and over-representation of the G/G genotype. 

Phrase: "our hypothesis testing data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0150098:Data Set [Intellectual Product]
   861   C1706233:Dataset [Intellectual Product]
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1511726:Data [Idea or Concept]
   812   C1705195:Set [Conceptual Entity]
   812   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "itself made up of two groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881534:Make [Functional Concept]

Phrase: "(sporadic AD"

Phrase: "and"

Phrase: "probands from a multicenter study of Alzheimer's disease sib pairs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0702111:probands [Organism Attribute]
   706 E C1948021:Proband [Family Group]

Phrase: "and"

Phrase: "small families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "each of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "essentially identical genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0439603:Frequencies [Temporal Concept]
   779 E C0376249:frequency [Quantitative Concept]
   779 E C0871396:Frequency [Quantitative Concept]
   779 E C1561548:Frequency [Qualitative Concept]
   779 E C1705502:Frequency [Quantitative Concept]
   729 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "over-representation of the G/G genotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205136:Over [Spatial Concept]
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]
Processing 00000000.tx.108: The A2M G/G effect was not dependent on APOE genotype and the effect was additive and substantial: the odds ratio of G/G in the presence of an APOE4 allele showed an almost 10-fold increased risk. 

Phrase: "The A2M G/G effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not dependent on APOE genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "additive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442796:Additive [Qualitative Concept]
  1000   C1550602:Additive [Substance]

Phrase: "and"

Phrase: "substantial"

Phrase: ":"

Phrase: "the odds ratio of G/G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028873:Odds Ratio [Quantitative Concept]
   783   C0201837:g ratio [Laboratory Procedure]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of an APOE4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Allele [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an almost 10-fold increased risk."
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   804   C0035647:Risk [Qualitative Concept]
   804   C0205217:Increased [Quantitative Concept]
   804   C0442805:Increased [Functional Concept]
   733 E C1517378:Gain [Quantitative Concept]
   711 E C0439661:Acquired [Temporal Concept]
   711 E C0442808:Increasing [Functional Concept]
   711 E C1301820:Obtain [Functional Concept]
   711 E C1706701:Acquire [Activity]
   711 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.109: Power analysis using the size of effect observed in our combined data set (using ~500 samples) suggests that a group size of 578 controls and 578 Alzheimer's disease patients would be necessary to have an [alpha] of 0.05 and a [beta] of 80% for the hypothesis that the G/G genotype is increased from 0.07 to 0.12 in Alzheimer's disease. 

Phrase: "Power analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the size of effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0814843:effect size [Quantitative Concept]
   770   C0456389:size [Spatial Concept]

Phrase: "observed in our combined data set"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0150098:Data Set [Intellectual Product]
   790   C1706233:Dataset [Intellectual Product]
   753   C0036849:Set [Mental Process]
   753   C0205195:Combined [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1442518:Set [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]
   719 E C0336789:Combine [Manufactured Object]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "~500 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a group size of 578 controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237884:group size [Group Attribute]
   753   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "578 Alzheimer's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "would"

Phrase: "be"

Phrase: "necessary to"

Phrase: "have"

Phrase: "an [alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439095:Alpha [Intellectual Product]
  1000   C2003941:Alpha [Intellectual Product]
  1000   C2350010:Alpha [Qualitative Concept]

Phrase: "]"

Phrase: "of 0.05"

Phrase: "and"

Phrase: "a [beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: "of 80%"

Phrase: "for the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "is"

Phrase: "increased from 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "to 0.12"

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.110: The association of the G/G A2M genotype as a risk factor in Alzheimer's disease leads to several interesting mechanistic interpretations. 

Phrase: "The association of the G/G A2M genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "as a risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035648:Risk factor [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "leads to several interesting mechanistic interpretations."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0459471:interpretations [Intellectual Product]
   753   C0543488:interesting [Mental Process]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   719 E C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.111: Previous data have shown that A2M immunostains SP and have implicated A2M in amyloid precursor protein metabolism (13) as well as possible interactions with binding of A[beta] (4) and mediation of degradation of A[beta] (5,6). 

Phrase: "Previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "immunostains"

Phrase: "SP"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "have"

Phrase: "implicated A2M in amyloid precursor protein metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1412046:A2M [Gene or Genome]

Phrase: "(13"

Phrase: ")"

Phrase: "as well as"

Phrase: "possible interactions with binding of A[beta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1704675:Interaction [Functional Concept]

Phrase: "]"

Phrase: "(4"

Phrase: ")"

Phrase: "and"

Phrase: "mediation of degradation of A[beta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680727:Mediation [Social Behavior]

Phrase: "]"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.112: A2M-A[beta] complexes undergo endocytosis via the A2M-r/LRP receptor (14). 

Phrase: "A2M-A[beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "] complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "undergo"

Phrase: "endocytosis via the A2M-r/LRP receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0014139:Endocytosis [Cell Function]
   738   C2984285:Endocytosis [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.113: A2M associates with A[beta] and prevents fibril formation (15). 

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "associates with A[beta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0330390:Beta [Plant]
   770   C0439096:Beta [Intellectual Product]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
   770   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.114: In addition, A2M can be viewed as a (sub)acute phase reactive molecule and as a potent proteinase inhibitor which might participate in the inflammatory response in Alzheimer brain. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "viewed as a (sub)acute phase reactive molecule"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0439557:Acute phase [Temporal Concept]
   744   C0205178:acute [Temporal Concept]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0542339:Sub- [Spatial Concept]
   744   C0567416:Molecule [Substance]
   744   C1264637:SUB [Quantitative Concept]
   711   C0449911:View [Spatial Concept]

Phrase: "and as a potent proteinase inhibitor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   790   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C2673177:proteinase inhibitor [Molecular Function]
   783   C0377149:proteinase a [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1515981:And [Idea or Concept]
   753   C1622131:proteinase [Molecular Function]
   753   C1947941:Proteinase [Enzyme]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "might"

Phrase: "participate in the inflammatory response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1155266:Inflammatory Response [Pathologic Function]
   760   C0333348:Inflammatory [Functional Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "in Alzheimer brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.115: Interestingly, A2M has also been implicated as a trophic factor, possibly as a result of binding and transporting a number of polypeptide growth factors and cytokines (16). 

Phrase: "Interestingly,"

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "implicated as a trophic factor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0960756:factor A [Organic Chemical]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]
   704   C0028707:Nutrition [Biomedical Occupation or Discipline]
   704   C0392209:nutrition [Organism Attribute]
   704   C1442959:Nutrition [Organism Function]

Phrase: "possibly as a result of binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2362652:Possibly [Qualitative Concept]
   753   C2825142:Result [Finding]

Phrase: "and"

Phrase: "transporting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "a number of polypeptide growth factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.116: Like apoE, A2M may serve as a binding protein for targeting various bioactive molecules to their site of action or clearing them (3). 

Phrase: "Like apoE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "may"

Phrase: "serve as a binding protein"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0033618:Protein Binding [Molecular Function]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "for targeting various bioactive molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "to their site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "or"

Phrase: "clearing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550003:Clearing [Idea or Concept]

Phrase: "them"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.117: Finally, the fact that apoE and APP, two other ligands of the A2M-r/LRP receptor are clearly involved in the pathophysiology of Alzheimer's disease, support the plausibility of the idea that an A2M polymorphism might contribute to risk of Alzheimer's disease. 

Phrase: "Finally,"

Phrase: "the fact"

Phrase: "that apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "of the A2M-r/LRP receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1412046:A2M gene [Gene or Genome]

Phrase: "are"

Phrase: "clearly"

Phrase: "involved in the pathophysiology of Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0031847:pathophysiology [Functional Concept]
   748   C0277785:Pathophysiology [Qualitative Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the plausibility of the idea"

Phrase: "that"

Phrase: "an A2M polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "might"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "risk of Alzheimer's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.118: In fact, a polymorphism in A2M-r/LRP itself has recently been reported in two studies to show a genetic association with Alzheimer's disease (17,18). 

Phrase: "In fact,"

Phrase: "a polymorphism in A2M-r/LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "itself"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported in two"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205448:Two [Quantitative Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a genetic association with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1328885:genetic association [Occupation or Discipline]
   783   C1511978:Disease Association [Temporal Concept]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.119: Although there is a strong biological rationale for the involvement of an A2M polymorphism in Alzheimer's disease, the possibility remains that the genetic association we observe reflects linkage with another mutation or polymorphism either in the A2M gene itself or in a nearby gene on chromosome 12. 

Phrase: "Although"

Phrase: "there"

Phrase: "is"

Phrase: "a strong biological rationale for the involvement of an A2M polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392360:Rationale [Idea or Concept]
   738   C2699007:Rationale [Idea or Concept]

Phrase: "in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the possibility"

Phrase: "remains"

Phrase: "that"

Phrase: "the genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "observe"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "linkage with another mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "or"

Phrase: "polymorphism either in the A2M gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0678951:gene polymorphism [Genetic Function]
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "itself"

Phrase: "or in a nearby gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.120: The A2M gene resides ~25 cM distal of the marker D12S1042, which yielded the maximal LOD score in a recent linkage study, suggesting that chromosome 12 contains an Alzheimer risk factor (19). 

Phrase: "The A2M gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412046:A2M gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "resides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "~25 cM"

Phrase: "distal of the marker D12S1042,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205108:Distal [Spatial Concept]

Phrase: "which"

Phrase: "yielded"

Phrase: "the maximal LOD score in a recent linkage study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0023956:Lod Score [Quantitative Concept]
   742   C0449820:Score [Quantitative Concept]
   742   C2247199:Lod [Molecular Function]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that chromosome 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an Alzheimer risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.121: However, the likelihood that A2M itself is a risk factor is supported by the results of a recent separate study, in which we observed an association between an intronic (5[prime] splice site of exon 18) pentanucleotide deletion (allele 2) within the A2M gene and Alzheimer's disease in a sibship analysis of Alzheimer's disease sib pairs and small Alzheimer's disease families (20). 

Phrase: "However,"

Phrase: "the likelihood"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0033204:Likelihood [Quantitative Concept]
   928 E C0332148:Likely [Qualitative Concept]
   928 E C0750492:Likely [Idea or Concept]

Phrase: "that A2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412046:A2M [Gene or Genome]

Phrase: "itself"

Phrase: "is"

Phrase: "a risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035648:Risk factor [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "supported by the results of a recent separate study,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   762   C0683954:results study [Finding]
   742   C0332185:Recent [Temporal Concept]
   742   C0443299:Separate [Spatial Concept]
   742   C0557651:Study [Manufactured Object]
   742   C1521721:Supported [Conceptual Entity]
   742   C2603343:Study [Research Activity]
   708 E C0183683:Support [Medical Device]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "in which"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an association between an intronic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "] splice site of exon 18"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "pentanucleotide deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "(allele 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "within the A2M gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412046:A2M gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease in a sibship analysis of Alzheimer's disease sib pairs"

Phrase: "and"

Phrase: "small Alzheimer's disease families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0344339:disease family [Finding]
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.122: Our current results extend this observation by showing linkage of a missense mutation in a case-control sample rather than family-based association. 

Phrase: "Our current results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this observation by showing linkage of a missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0302523:Observation [Research Activity]
   742   C0700325:observation [Health Care Activity]
   742   C1964257:Observation [Diagnostic Procedure]

Phrase: "in a case-control sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
   734   C0872128:case control [Health Care Activity]

Phrase: "rather than"

Phrase: "family-based association."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0544093:Association, familial [Finding]
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.123: We are currently studying how the two A2M polymorphisms relate to one another; 

Phrase: "We"

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "studying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "how"

Phrase: "the two A2M polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "relate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0163712:Relate [Organic Chemical]

Phrase: "to one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "another"

Phrase: ";"
Processing 00000000.tx.124: our preliminary results are consistent with the hypothesis that they act as independent risk factors. 

Phrase: "our preliminary results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "they"

Phrase: "act as independent risk factors."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   760   C0035647:Risk [Qualitative Concept]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.125: Initial study of a group evaluated for both polymorphisms suggests that the G allele is inherited with the 1 allele; 

Phrase: "Initial study of a group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205265:Initial [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1279901:Initial [Qualitative Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "evaluated for both polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0032529:polymorphisms [Genetic Function]
   770   C0220825:Evaluated [Functional Concept]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "inherited with the 1 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002085:Allele [Gene or Genome]
   760   C0439660:Inherited [Functional Concept]

Phrase: ";"
Processing 00000000.tx.126: of 70 G chromosomes examined (35 G/G individuals), 97% were allele 1 and 3% were allele 2, compared with an allele 2 frequency of ~15% (P < 0.005, [chi]2 analysis with Yate's correction). 

Phrase: "of 70 G chromosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0008648:g chromosome [Cell Component]
   827   C0008633:Chromosomes [Cell Component]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(35 G/G individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: ")"

Phrase: ","

Phrase: "97%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "were"

Phrase: "allele 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "3%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "were"

Phrase: "allele 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "compared with an allele 2 frequency of ~15%"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0017270:Allele Frequency [Quantitative Concept]
   744   C0002085:Allele [Gene or Genome]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]
   744   C1707455:Compared [Activity]

Phrase: "(P < 0.005,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "[chi]2 analysis with Yate's correction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: ")."
Processing 00000000.tx.127: Taken together, we believe that polymorphisms in the A2M gene may contribute to risk for Alzheimer's disease. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "we"

Phrase: "believe"

Phrase: "that polymorphisms in the A2M gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0678951:gene polymorphisms [Genetic Function]
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "risk for Alzheimer's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.128: Moreover, these data focus attention on mechanisms of pathophysiology that impact on A2M-r/LRP or its ligands, including clearance mechanisms mediated by A2M-r/LRP (7,14), and suggest that other A2M-r/LRP ligands may be candidate Alzheimer's disease genes as well. 

Phrase: "Moreover,"

Phrase: "these data focus attention on mechanisms of pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0589098:focus attention [Mental Process]
   744   C0004268:Attention [Mental Process]

Phrase: "that impact on A2M-r/LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1825598:IMPACT gene [Gene or Genome]
           IMPACT

Phrase: "or"

Phrase: "its ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "clearance mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "mediated by A2M-r/LRP"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   818   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   764   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0079423:R Gene [Gene or Genome]
   762   C0168981:protein r [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   762   C1335671:Receptor Gene [Gene or Genome]
   762   C1412046:A2M gene [Gene or Genome]
           A2M
   742   C0017337:Gene [Gene or Genome]
   742   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205090:R- [Spatial Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0684010:R. [Professional or Occupational Group]
   742   C2603358:R' [Clinical Attribute]

Phrase: "(7,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other A2M-r/LRP ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   834   C1621296:receptor ligand [Molecular Function]
   793   C0023688:Ligands [Chemical]
   711   C1412046:A2M gene [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "candidate Alzheimer's disease genes as well."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Genes
   753   C0017337:Genes [Gene or Genome]
   745   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.129: MATERIALS AND METHODS Subjects An initial hypothesis generating data set was established from 171 Alzheimer's disease patients with a clinical history of probable Alzheimer's disease and 90 age-compatible control individuals, who were primarily spouses of the patients. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "An initial hypothesis generating data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0150098:Data Set [Intellectual Product]
   840   C1706233:Dataset [Intellectual Product]
   804   C0036849:Set [Mental Process]
   804   C1442518:Set [Functional Concept]
   804   C1511726:Data [Idea or Concept]
   804   C1705195:Set [Conceptual Entity]
   804   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "established from 171 Alzheimer's disease patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]

Phrase: "with a clinical history"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "of probable Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "90 age-compatible control individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0027361:Individual [Population Group]
   771   C0237401:Individual [Human]

Phrase: "who"

Phrase: "were"

Phrase: "primarily spouses of the patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162409:Spouses [Family Group]
Processing 00000000.tx.130: A second hypothesis testing data set was collected from several sources in an attempt to approximate the >500 patients and controls estimated by power analysis to adequately test the hypothesis that the G/G genotype is over-represented in Alzheimer's disease. 

Phrase: "A second hypothesis testing data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0150098:Data Set [Intellectual Product]
   840   C1706233:Dataset [Intellectual Product]
   804   C0036849:Set [Mental Process]
   804   C1442518:Set [Functional Concept]
   804   C1511726:Data [Idea or Concept]
   804   C1705195:Set [Conceptual Entity]
   804   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "collected from several sources"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449416:sources [Finding]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   737 E C1705919:Source [Idea or Concept]

Phrase: "in an attempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to approximate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximate [Qualitative Concept]

Phrase: "the >500 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "estimated by power analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0032863:Power [Human-caused Phenomenon or Process]
   770   C0750572:Estimated [Quantitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "to adequately"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the G/G genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C1319635:g/g [Quantitative Concept]

Phrase: "is"

Phrase: "over-represented in Alzheimer's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205136:Over [Spatial Concept]
   726   C1882932:Represent [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.131: These individuals included additional cases of 380 sporadic Alzheimer disease and 337 controls matched for site (primarily cognitively tested spouses) collected from the Massachusetts General Hospital Memory Disorder Unit and from a consortium of European Centers (University of Hamburg, Germany, University of Basel, Switzerland and S. Cuore Fatebenefratelli Hospital, Brescia, Italy) and 179 probands from a multicenter study of Alzheimer disease sib pairs and small Alzheimer's disease families (21). 

Phrase: "These individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "additional cases of 380 sporadic Alzheimer disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "337 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "matched for site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0150103:matched [Research Activity]
   790   C0205145:Site [Spatial Concept]
   790   C1515974:Site [Body Location or Region]
   790   C1708943:Matched [Qualitative Concept]
   790   C2825164:Site [Spatial Concept]

Phrase: "(primarily cognitively tested spouses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0162409:Spouses [Family Group]

Phrase: ")"

Phrase: "collected from the Massachusetts General Hospital Memory Disorder Unit"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   764   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   764   C0025261:memory disorder [Mental or Behavioral Dysfunction]
   762   C0019988:hospital unit [Health Care Related Organization]
   742   C0012634:Disorder [Disease or Syndrome]
   742   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   742   C0024874:Massachusetts [Geographic Area]
   742   C0025260:Memory [Mental Process]
   742   C0205246:General [Spatial Concept]
   742   C0439148:Unit [Quantitative Concept]
   742   C0700327:memory [Finding]
   742   C1510665:Hospital [Qualitative Concept]
   742   C1516695:Collected [Idea or Concept]
   742   C1516698:Collected [Functional Concept]
   742   C1519795:Unit [Quantitative Concept]
   742   C1553889:General [Idea or Concept]
   742   C1704753:Unit [Manufactured Object]
   742   C1706377:Memory [Manufactured Object]
   742   C1880519:Unit [Quantitative Concept]

Phrase: "and from a consortium of European Centers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205099:centers [Spatial Concept]
   748   C0239307:European [Population Group]
   748   C1513822:Consortium [Professional or Occupational Group]
   748   C1515981:And [Idea or Concept]
   748   C1535514:European [Population Group]
   748   C1880171:Consortium [Professional or Occupational Group]

Phrase: "(University of Hamburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "University of Basel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "and"

Phrase: "S. Cuore Fatebenefratelli Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Brescia,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "179 probands from a multicenter study of Alzheimer disease sib pairs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0702111:probands [Organism Attribute]
   704 E C1948021:Proband [Family Group]

Phrase: "and"

Phrase: "small Alzheimer's disease families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0344339:disease family [Finding]
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.132: A2M polymorphism genotyping Genomic DNA isolated from brain tissue and blood was amplified by PCR in the presence of oligonucleotide sense primer C23 (5[prime]-ATC CCT GAA ACT GCC ACC AA-3[prime]) and antisense primer AS24 (5[prime]-GTA ACT GAA ACC TAC TGG AA-3[prime]), 10 mM Tris-HC1, 50 mM KC1 (pH 8.3), 1.5 mM MgC12, 5 mM dNTPs, 5 pmol each primer and 1.25 U Taq DNA polymerase. 

Phrase: "A2M polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "genotyping"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
   966 E C0017431:Genotype [Organism Attribute]

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "isolated from brain tissue"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0440746:Brain tissue [Tissue]
   833   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C0205409:Isolated [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1547928:Tissue [Intellectual Product]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of oligonucleotide sense primer C23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1417613:C23 [Gene or Genome]
   708   C0206415:Oligonucleotide Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-ATC CCT GAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1414899:GAA [Gene or Genome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "GCC ACC AA-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0444860:Aa 3 [Intellectual Product]
   812   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   812   C0282160:ACC [Congenital Abnormality]
   812   C1235746:Aa [Plant]
   812   C1882141:aa [Qualitative Concept]
   812   C3541413:ACC [Gene or Genome]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: ")"

Phrase: "and"

Phrase: "antisense primer AS24"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-GTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2697657:GTA [Gene or Genome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "GAA ACC TAC TGG AA-3"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0444860:Aa 3 [Intellectual Product]
   799   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   799   C0282160:ACC [Congenital Abnormality]
   799   C1235746:Aa [Plant]
   799   C1414899:GAA [Gene or Genome]
   799   C1882141:aa [Qualitative Concept]
   799   C1883257:TAC [Therapeutic or Preventive Procedure]
   799   C2962221:TAC [Pharmacologic Substance]
   799   C2986848:TAC [Quantitative Concept]
   799   C3541413:ACC [Gene or Genome]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "10 mM Tris-HC1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1539205:HC1 [Gene or Genome]

Phrase: "50 mM KC1"

Phrase: "(pH 8.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "1.5 mM MgC12,"

Phrase: "5 mM dNTPs,"

Phrase: "5 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "each primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "1.25 U Taq DNA polymerase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   861   C2257065:Taq DNA polymerase [Genetic Function]
   827   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.133: The PCR was carried out in a touchdown procedure that stepped down the annealing temperature to increase primer specificity as follows: one cycle at 94C for 5 min; 

Phrase: "The PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a touchdown procedure"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C0912256:Touchdown [Amino Acid, Peptide, or Protein,Organophosphorus Compound,Pharmacologic Substance]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]

Phrase: "that"

Phrase: "stepped down the annealing temperature to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]
   719   C1261552:Step [Conceptual Entity]
   719   C1704379:Step [Functional Concept]
   719   C1705117:Step [Quantitative Concept]
   719   C2825408:Step [Manufactured Object]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "primer specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "one cycle at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511572:Cycle [Temporal Concept]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.134: four cycles at 94C for 30 s, 65C for 30 s, 72C for 1 min; 

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "cycles at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s,"

Phrase: "65C for 30 s,"

Phrase: "72C for 1 min"

Phrase: ";"
Processing 00000000.tx.135: four cycles at 94C for 30 s, 62C for 30 s, 72C for 1 min; 

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "cycles at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s,"

Phrase: "62C for 30 s,"

Phrase: "72C for 1 min"

Phrase: ";"
Processing 00000000.tx.136: four cycles at 94C for 30 s, 59C for 30 s, 72C for 1 min; 

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "cycles at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s,"

Phrase: "59C for 30 s,"

Phrase: "72C for 1 min"

Phrase: ";"
Processing 00000000.tx.137: 20 cycles at 94C for 30 s, 56C for 30 s, 72C for 1 min; 

Phrase: "20 cycles at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s,"

Phrase: "56C for 30 s,"

Phrase: "72C for 1 min"

Phrase: ";"
Processing 00000000.tx.138: one cycle at 72C for 5 min. 

Phrase: "one cycle at 72C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511572:Cycle [Temporal Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.139: In each reaction mixture, MboI was added to the amplified product of 615 bp and digestion carried out at 37C for 3 h, producing fragments of 532 (G allele) or 429 bp (A allele). 

Phrase: "In each reaction mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "MboI"

Phrase: "was"

Phrase: "added to the amplified product of 615 bp"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C1514468:product [Entity]
   744   C1524062:Added [Functional Concept]
   744   C1704444:Product [Quantitative Concept]
   711 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at 37C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "for 3 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "producing"

Phrase: "fragments of 532"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332255:fragments [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   756 E C1708096:Fragment [Qualitative Concept]

Phrase: "(G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "429 bp ("

Phrase: "A allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.140: The digested product was loaded onto a 2% agarose gel treated with ethidium bromide (0.005%) and electrophoresed for 2 h under constant voltage (150 V), which is sufficient to separate the digested product so that the 532 and 429 bp bands can be distinguished. 

Phrase: "The digested product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "loaded onto a 2% agarose gel"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1382104:Gel [Substance]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "treated with ethidium bromide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(0.005%"

Phrase: ")"

Phrase: "and"

Phrase: "electrophoresed for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0013855:electrophorese [Laboratory Procedure]

Phrase: "under constant voltage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444887:Constant voltage [Natural Phenomenon or Process]
   861   C0598352:Voltage [Quantitative Concept]

Phrase: "(150 V),"

Phrase: "which"

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "the digested product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the 532"

Phrase: "and"

Phrase: "429 bp bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "can"

Phrase: "be"

Phrase: "distinguished."
Processing 00000000.tx.141: After electrophoresis, DNA fragments were visualized by UV illumination using a Bio-Rad Gel Doc system. 

Phrase: "After electrophoresis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "DNA fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "visualized by UV illumination"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023693:Illumination [Natural Phenomenon or Process]
   770   C0023700:Illumination [Human-caused Phenomenon or Process]
   770   C0041625:UV [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C0684292:illumination [Laboratory Procedure]
   770   C1961129:uV [Quantitative Concept]
   770   C1964256:Illumination [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bio-Rad Gel Doc system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.142: Incomplete digestion was monitored by the continued presence of the 615 bp product. 

Phrase: "Incomplete digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "was"

Phrase: "monitored by the continued presence of the 615 bp product."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   741   C0026426:bp monitor [Health Care Activity]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0549178:Continued [Idea or Concept]
   739   C1514468:product [Entity]
   739   C1704444:Product [Quantitative Concept]
   706   C0030695:monitor [Health Care Activity]
   706   C0150369:monitor [Health Care Activity]
   706   C0181904:Monitor [Medical Device]
   706   C0596972:Monitor [Medical Device]
   706   C1521743:Monitor [Professional or Occupational Group]
   706   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.143: Immunohistochemical analysis used anti-A2M antibody (1:500) from Zymed. 

Phrase: "Immunohistochemical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1524024:analysis [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-A2M antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "from Zymed."
Processing 00000000.tx.144: A goat Cy3-linked secondary antibody (Jackson Immunoresearch) was used to visualize immunostaining. 

Phrase: "A goat Cy3-linked secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson Immunoresearch"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "immunostaining."
Processing 00000000.tx.145: In some instances, double immunofluorescence was carried out with an A[beta] counterstain (antibody 10D5, courtesy of Dr D. Schenk, Athena Neurosciences) using bodipy-fluorescein-linked secondary antibody (Molecular Probes) as the second fluorochrome. 

Phrase: "In some instances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550608:Instance [Idea or Concept]

Phrase: "double immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with an A[beta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C2004068:Beta [Qualitative Concept]

Phrase: "] counterstain"

Phrase: "(antibody 10D5,"

Phrase: "courtesy of Dr D. Schenk,"

Phrase: "Athena Neurosciences"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027910:Neurosciences [Biomedical Occupation or Discipline]
   827 E C1552241:Neuroscience [Professional or Occupational Group]
   827 E C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bodipy-fluorescein-linked secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "as the second fluorochrome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.146: Quantitative neuropathological techniques for measuring A[beta] burden and neurofibrillary tangles number in the superior temporal sulcus area have been previously published (12). 

Phrase: "Quantitative neuropathological techniques for measuring A[beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025664:techniques [Intellectual Product]
   748   C0449851:Techniques [Functional Concept]

Phrase: "] burden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "neurofibrillary tangles number in the superior temporal sulcus area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.147: Statistical methods Comparisons of A2M allele frequency (proportion of chromosomes in which an allele is present) and genotype frequency (proportion of individuals with a genotype) were performed with 2  2 tables using Fisher's exact test for significance. 

Phrase: "Statistical methods Comparisons of A2M allele frequency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707455:Comparison [Activity]

Phrase: "(proportion of chromosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709707:Proportion [Quantitative Concept]
   718 E C0205351:Proportional [Qualitative Concept]

Phrase: "in which"

Phrase: "an allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "genotype frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "(proportion of individuals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709707:Proportion [Quantitative Concept]
   718 E C0205351:Proportional [Qualitative Concept]

Phrase: "with a genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "performed with 2  2 tables"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0039224:tables [Manufactured Object]
   760   C0884358:Performed [Functional Concept]
   760   C1706074:Tables [Intellectual Product]
   726 E C1706073:Table [Medical Device]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fisher's exact test for significance."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0325045:Fisher [Mammal]
   760   C0392366:test [Intellectual Product]
   760   C2828393:Exact [Qualitative Concept]
Processing 00000000.tx.148: Age of onset of Alzheimer's disease was normally distributed and compared by t-test. 

Phrase: "Age of onset of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "normally"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "compared by t-test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.149: Multivariate analysis for odds of Alzheimer's disease was performed by logistic regression with APOE genotype coded according to the presence or absence of APOE4. 

Phrase: "Multivariate analysis for odds of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0026777:Multivariate Analysis [Quantitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by logistic regression"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0206031:Logistic Regression [Research Activity]
   833   C1550369:Performed By [Qualitative Concept]
   770   C0242415:logistic [Occupational Activity]
   770   C0684320:Regression [Pathologic Function]
   770   C0684321:Regression [Mental Process]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "coded according to the presence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
   760   C0680240:according [Social Behavior]
   726   C0009219:code [Occupational Activity]
   726   C0805701:Code [Intellectual Product]

Phrase: "or"

Phrase: "absence of APOE4."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.150: Similar results were obtained when the group with APOE4 was coded separately as heterozygotes or homozygotes for this allele. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "the group with APOE4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "coded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0009219:code [Occupational Activity]
   966   C0805701:Code [Intellectual Product]

Phrase: "separately as heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019425:Heterozygotes [Organism Attribute]

Phrase: "or"

Phrase: "homozygotes for this allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.151: Odds ratios are presented with 95% confidence intervals (CIs). 

Phrase: "Odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "presented with 95% confidence intervals (CIs)."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0009667:Confidence Intervals [Quantitative Concept]
   760   C0237529:Confidence [Mental Process]
   760   C0449450:Presented [Idea or Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1704725:Confidence [Qualitative Concept]
   760   C1704726:Confidence [Mental Process]
   726 E C0150312:Present [Quantitative Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.152: All analyses were performed with Stata software (College Park, TX). 

Phrase: "All analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed with Stata software"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(College Park,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557806:College [Manufactured Object]
   861   C0562547:Park [Manufactured Object]
   861   C3160718:PARK [Disease or Syndrome]

Phrase: "TX"

Phrase: ")."
Processing 00000000.tx.153: All significance tests were two-tailed. 

Phrase: "All significance tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "two-tailed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039259:tailed [Body Part, Organ, or Organ Component]
   861   C0205448:Two [Quantitative Concept]
Processing 00000000.tx.154: ACKNOWLEDGEMENTS We thank C. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.155: Maschke for technical assistance. 

Phrase: "Maschke for technical assistance."
Processing 00000000.tx.156: We thank the Massachusetts Alzheimer's Research Center (AG05134) Brain Bank (Dr E.T. Hedley-Whyte) for neuropathological specimens. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the Massachusetts Alzheimer's Research Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "(AG05134"

Phrase: ")"

Phrase: "Brain Bank"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442598:Bank [Manufactured Object]
   861   C0872261:Bank [Manufactured Object]

Phrase: "(Dr E.T. Hedley-Whyte"

Phrase: ")"

Phrase: "for neuropathological specimens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]
Processing 00000000.tx.157: Additional neurological pathological specimens were obtained from the Brain Tissue Research Center (MH/NS 31862). 

Phrase: "Additional neurological pathological specimens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   825   C0444061:pathology specimens [Body Substance]
   812   C0370003:specimens [Substance]
   779 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from the Brain Tissue Research Center"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0440746:Brain tissue [Tissue]
   778   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   778   C0683939:research center [Manufactured Object,Organization]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0035168:research [Research Activity]
   748   C0040300:Tissue [Tissue]
   748   C0205099:Center [Spatial Concept]
   748   C0242481:Research [Research Activity]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1301820:Obtained [Functional Concept]
   748   C1547928:Tissue [Intellectual Product]
   714 E C1706701:Obtain [Activity]

Phrase: "(MH/NS 31862"

Phrase: ")."
Processing 00000000.tx.158: This work was supported by NIH grants AG12406 and AG08487. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by NIH grants AG12406"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0018173:Grants [Quantitative Concept]
   760   C0027468:NIH [Health Care Related Organization]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "AG08487."
Processing 00000000.tx.159: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.160: Bauer,J., Strauss,S., Schreiter-Gasser,U., Ganter,U., Schlegel,P., Witt,I., Yolk,B. and Berger,M. 

Phrase: "Bauer,"

Phrase: "J.,"

Phrase: "Strauss,"

Phrase: "S."

Phrase: ","

Phrase: "Schreiter-Gasser,"

Phrase: "U.,"

Phrase: "Ganter,"

Phrase: "U.,"

Phrase: "Schlegel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Witt,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yolk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2610566:yolk [Cell Component]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Berger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.161: (1991) Interleukin-6 and alpha 2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Interleukin-6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "alpha 2-macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "indicate"

Phrase: "an acute-phase state in Alzheimer's disease cortices."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0001349:Acute-Phase State [Pathologic Function]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
Processing 00000000.tx.162: FEBS Lett., 285, 111-114. 

Phrase: "FEBS Lett.,"

Phrase: "285,"

Phrase: "111-114."
Processing 00000000.tx.163: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.164: Van Gool,D., De Strooper,B., Van Leuven,F., Triau,E. and Dom,R. 

Phrase: "Van Gool,"

Phrase: "D."

Phrase: ","

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Triau,"

Phrase: "E."

Phrase: "and"

Phrase: "Dom,R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.165: (1993) [alpha]2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "[alpha]2-Macroglobulin expression in neuritic-type plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.166: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.167: Aging, 14, 233-237. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "14,"

Phrase: "233-237."
Processing 00000000.tx.168: MEDLINE Abstract 3. 

Phrase: "MEDLINE Abstract 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.169: Rebeck,G.W., Harr,S.D., Strickland,D.K. and Hyman,B.T. 

Phrase: "Rebeck,"

Phrase: "G.W., Harr,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Strickland,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.170: (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Multiple, diverse senile plaque-associated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "ligands of an apolipoprotein E receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1621296:receptor ligand [Molecular Function]
   753   C0023688:Ligands [Chemical]

Phrase: "the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein."
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   891   C1158819:alpha protein [Genetic Function]
   891   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   857   C0023821:Alpha-lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   857   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   846   C0242972:low protein [Therapeutic or Preventive Procedure]
   846   C0748025:low protein [Finding]
   840   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   821   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   813   C0599283:receptor density [Genetic Function]
   790   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0178587:density [Quantitative Concept]
   790   C0205251:low [Qualitative Concept]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   790   C1299352:Low [Qualitative Concept]
   790   C1550472:low [Idea or Concept]
   756 E C0163712:Relate [Organic Chemical]
   718 E C0080103:Relation [Family Group]
   718 E C0439794:Dense [Qualitative Concept]
   718 E C0869014:Relations [Social Behavior]
Processing 00000000.tx.171: Ann. 

Phrase: "Ann."
Processing 00000000.tx.172: Neurol., 37, 211-217. 

Phrase: "Neurol.,"

Phrase: "37,"

Phrase: "211-217."
Processing 00000000.tx.173: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.174: Du,Y., Ni,B., Glinn,M., Dodel,R.C., Bales,K.R., Zhang,Z., Hyslop,P.A. and Paul,S.M. 

Phrase: "Du,Y.,"

Phrase: "Ni,B.,"

Phrase: "Glinn,"

Phrase: "M."

Phrase: ","

Phrase: "Dodel,"

Phrase: "R.C., Bales,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C2826220:BALE [Quantitative Concept]
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Hyslop,"

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Paul,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.175: (1997) Alpha 2-macroglobulin as a beta-amyloid peptide-binding plasma protein. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alpha 2-macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "as a beta-amyloid peptide-binding plasma protein."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   911   C1864725:BETA-AMYLOID PEPTIDE-BINDING PROTEIN [Gene or Genome]
   893   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   884   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   877   C1750295:beta protein [Genetic Function]
   877   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   861   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   829   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0032105:Plasma [Body Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.176: J. 

Phrase: "J."
Processing 00000000.tx.177: Neurochem., 69, 299-305. 

Phrase: "Neurochem.,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "299-305."
Processing 00000000.tx.178: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.179: Qiu,W.Q. 

Phrase: "Qiu,"

Phrase: "W.Q."
Processing 00000000.tx.180: (1996) Degradation of amyloid beta-protein by a serine protease alpha 2-macroglobulin complex. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Degradation of amyloid beta-protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by a serine protease alpha 2-macroglobulin complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.181: J. 

Phrase: "J."
Processing 00000000.tx.182: Biol. 

Phrase: "Biol."
Processing 00000000.tx.183: Chem., 271, 8443-8451. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "8443-8451."
Processing 00000000.tx.184: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.185: Zhang,Z., Drzewiecki,G.J., May,P.C., Rydel,R.E., Paul,S.M. and Hyslop,P.A. 

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Drzewiecki,"

Phrase: "G.J.,"

Phrase: "May,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Rydel,"

Phrase: "R.E.,"

Phrase: "Paul,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Hyslop,"

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.186: (1996) Inhibition of alpha 2-macroglobulin/proteinase-mediated degradation of amyloid beta peptide by apolipoprotein E and alpha 1-antichymotrypsin. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Inhibition of alpha 2-macroglobulin/proteinase-mediated degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "of amyloid beta peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "by apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "alpha 1-antichymotrypsin."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002190:alpha 1-Antichymotrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412050:ANTICHYMOTRYPSIN, ALPHA-1 [Gene or Genome]
   901   C1879647:Alpha1 [Qualitative Concept]
   901   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   827   C0439095:Alpha [Intellectual Product]
   827   C0443619:Antichymotrypsin [Amino Acid, Peptide, or Protein]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.187: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.188: J. 

Phrase: "J."
Processing 00000000.tx.189: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.190: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.191: Invest., 3, 156-161. 

Phrase: "Invest.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "156-161."
Processing 00000000.tx.192: 7. 

Phrase: "7."
Processing 00000000.tx.193: Rebeck,G.W., Reiter,J.S., Strickland,D.K. and Hyman,B.T. 

Phrase: "Rebeck,"

Phrase: "G.W., Reiter,"

Phrase: "J.S.,"

Phrase: "Strickland,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.194: (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E in sporadic Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "allelic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "receptor interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1372999:Receptor Interactions [Molecular Function]
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.195: Neuron, 11, 575-580. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "11,"

Phrase: "575-580."
Processing 00000000.tx.196: MEDLINE Abstract 8. 

Phrase: "MEDLINE Abstract 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.197: Strickland,D.K., Ashcom,J.D., Williams,S., Burgess,W.H., Migliorini,M. and Argraves,W.S. 

Phrase: "Strickland,"

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ashcom,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Williams,"

Phrase: "S."

Phrase: ","

Phrase: "Burgess,"

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Migliorini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Argraves,"

Phrase: "W.S."
Processing 00000000.tx.198: (1990) Sequence identity between the [alpha]2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "identity between the [alpha]2-macroglobulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0424215:Identity [Mental Process]
   748   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "a multifunctional receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.199: J. 

Phrase: "J."
Processing 00000000.tx.200: Biol. 

Phrase: "Biol."
Processing 00000000.tx.201: Chem., 265, 17401-17404. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "265,"

Phrase: "17401-17404."
Processing 00000000.tx.202: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.203: Kounnas,M., Moir,R., Rebeck,G., Bush,A., Argraves,W., Tanzi,R., Hyman,B.T. and Strickland,D. 

Phrase: "Kounnas,"

Phrase: "M."

Phrase: ","

Phrase: "Moir,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rebeck,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A.,"

Phrase: "Argraves,"

Phrase: "W.,"

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.204: (1995) LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted [beta]-amyloid precursor protein and mediates its degradation. 

Phrase: "(1995"

Phrase: ")"

Phrase: "LDL receptor-related protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0051300:LDL-Receptor Related Protein [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a multifunctional ApoE receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "[beta]-amyloid precursor protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "its degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.205: Cell, 82, 331-340. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "82,"

Phrase: "331-340."
Processing 00000000.tx.206: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.207: Poller,W., Faber,J.P., Klobeck,G. and Olek,K. 

Phrase: "Poller,"

Phrase: "W.,"

Phrase: "Faber,"

Phrase: "J.P.,"

Phrase: "Klobeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Olek,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.208: (1992) Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cloning of the human alpha 2-macroglobulin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0525049:Human Cloning [Research Activity]
   767   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "detection of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1513778:Mutation Detection [Laboratory Procedure]
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in two functional domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: ":"

Phrase: "the bait region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the thiolester site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.209: Hum. 

Phrase: "Hum."
Processing 00000000.tx.210: Genet., 88, 313-319. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "88,"

Phrase: "313-319."
Processing 00000000.tx.211: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.212: Blessed,G., Tomlinson,B.E. and Roth,M. 

Phrase: "Blessed"

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tomlinson,"

Phrase: "B.E."

Phrase: "and"

Phrase: "Roth,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.213: (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. 

Phrase: "(1968"

Phrase: ")"

Phrase: "The association between quantitative measures of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and of senile change"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0392079:Senile [Finding]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1705241:Change [Quantitative Concept]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "in the cerebral grey matter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral gray matter [Body Part, Organ, or Organ Component]
   901   C0018220:Gray matter [Tissue]
   827   C0556636:gray [Quantitative Concept]
   827   C1269776:Gray [Qualitative Concept]

Phrase: "of elderly subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.214: Br. 

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.215: J. 

Phrase: "J."
Processing 00000000.tx.216: Psychiat., 114, 797-811. 

Phrase: "Psychiat.,"

Phrase: "114,"

Phrase: "797-811."
Processing 00000000.tx.217: 12. 

Phrase: "12."
Processing 00000000.tx.218: Gmez-Isla,T., Hollister,R., West,H.L., Mui,S., Growdon,J., Petersen,R., Parisi,J. and Hyman,B.T. 

Phrase: "Gmez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hollister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "H.L., Mui,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Growdon,"

Phrase: "J.,"

Phrase: "Petersen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Parisi,"

Phrase: "J."

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.219: (1997) Neuronal loss parallels but exceeds tangle formation in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuronal loss parallels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2348042:Parallel [Qualitative Concept]
   793   C2826345:PARALLEL [Research Activity]
   734   C1850496:Neuronal loss [Finding]

Phrase: "but"

Phrase: "exceeds"

Phrase: "tangle formation in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.220: Ann. 

Phrase: "Ann."
Processing 00000000.tx.221: Neurol., 41, 17-24. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "17-24."
Processing 00000000.tx.222: MEDLINE Abstract 13. 

Phrase: "MEDLINE Abstract 13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.223: Ganter,U., Strauss,S., Jonas,U., Weidemann,A., Beyreuther,K., Volk,B., Berger,M. and Bauer,J. 

Phrase: "Ganter,"

Phrase: "U.,"

Phrase: "Strauss,"

Phrase: "S."

Phrase: ","

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "U.,"

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Volk,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Berger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bauer,"

Phrase: "J."
Processing 00000000.tx.224: (1991) Alpha 2-macroglobulin synthesis in interleukin-6 stimulated human neuronal (SH-SY5Y neuroblastoma) cells. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Alpha 2-macroglobulin synthesis in interleukin-6 stimulated human"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C1155201:interleukin-6 synthesis [Molecular Function]
   781   C1155093:interleukin-2 synthesis [Molecular Function]
   742   C0220781:synthesis [Biologic Function]
   742   C1883254:Synthesis [Activity]

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "(SH-SY5Y neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.225: FEBS Lett., 282, 127-131. 

Phrase: "FEBS Lett.,"

Phrase: "282,"

Phrase: "127-131."
Processing 00000000.tx.226: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.227: Narita,M., Holtzman,D., Schwartz,A. and Bu,G. 

Phrase: "Narita,"

Phrase: "M."

Phrase: ","

Phrase: "Holtzman,"

Phrase: "D."

Phrase: ","

Phrase: "Schwartz,"

Phrase: "A."

Phrase: "and"

Phrase: "Bu,G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.228: (1997) Alpha-2 macroglobulin complexes with and mediates the endocytosis of [beta] amyloid peptide via cell surface low-density lipoprotein receptor related protein. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin complexes with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the endocytosis of [beta] amyloid peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C2825879:Amyloid, Beta [Laboratory Procedure]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C2004068:Beta [Qualitative Concept]

Phrase: "via cell surface low-density lipoprotein receptor related protein."
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
   878   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C0034800:Cell Surface Receptor [Amino Acid, Peptide, or Protein,Receptor]
   864   C0242972:low protein [Therapeutic or Preventive Procedure]
   864   C0748025:low protein [Finding]
   861   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   861   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   836   C0162339:Cell Density [Quantitative Concept]
   835   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   822   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   812   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0178587:density [Quantitative Concept]
   793   C0205251:low [Qualitative Concept]
   793   C0439849:Related [Qualitative Concept]
   793   C0445223:Related [Finding]
   793   C1299352:Low [Qualitative Concept]
   793   C1550472:low [Idea or Concept]
   760 E C0163712:Relate [Organic Chemical]
   721 E C0080103:Relation [Family Group]
   721 E C0439794:Dense [Qualitative Concept]
   721 E C0869014:Relations [Social Behavior]
Processing 00000000.tx.229: J. 

Phrase: "J."
Processing 00000000.tx.230: Neurochem., 69, 1904-1911. 

Phrase: "Neurochem.,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "1904-1911."
Processing 00000000.tx.231: MEDLINE Abstract 15. 

Phrase: "MEDLINE Abstract 15."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.232: Hughes,S., Khorkova,O., Goyal,S., Knaeblein,J., Heroux,J., Reidel,N. and Sahasrabudhe,S. 

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Khorkova,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Goyal,"

Phrase: "S."

Phrase: ","

Phrase: "Knaeblein,"

Phrase: "J.,"

Phrase: "Heroux,"

Phrase: "J.,"

Phrase: "Reidel,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Sahasrabudhe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.233: (1998) Alpha-2-macroglobulin associates with [beta] amyloid peptide and prevents fibril formation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alpha-2-macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "associates with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0750490:Associate [Idea or Concept]
   833   C1706221:Associate [Professional or Occupational Group]

Phrase: "[beta] amyloid peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "fibril formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.234: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.235: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.236: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.237: USA, 95, 3275-3280. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "3275-3280."
Processing 00000000.tx.238: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.239: Borth,W. 

Phrase: "Borth,"

Phrase: "W."
Processing 00000000.tx.240: (1992) [alpha]2-Macroglobulin, a multifunctional binding protein with targeting characteristics. 

Phrase: "(1992"

Phrase: ")"

Phrase: "[alpha]2-Macroglobulin,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "a multifunctional binding protein with targeting characteristics."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0033618:Protein Binding [Molecular Function]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C1159372:Protein Targeting [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
Processing 00000000.tx.241: FASEB J., 6, 3345-3353. 

Phrase: "FASEB J.,"

Phrase: "6,"

Phrase: "3345-3353."
Processing 00000000.tx.242: MEDLINE Abstract 17. 

Phrase: "MEDLINE Abstract 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.243: Kang,D.E., Saitoh,T., Chen,X., Xia,Y., Masliah,E., Hansen,L.A., Thomas,R.G., Thal,L.J. and Katzman,R. 

Phrase: "Kang,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Hansen,"

Phrase: "L.A.,"

Phrase: "Thomas,"

Phrase: "R.G.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Katzman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.244: (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic association of the low-density lipoprotein receptor-related protein gene (LRP),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C1328885:genetic association [Occupation or Discipline]
   738   C0004083:Association [Mental Process]
   738   C0439849:Association [Qualitative Concept]
   738   C0596306:Association [Phenomenon or Process]
   738   C0699792:association [Social Behavior]

Phrase: "an apolipoprotein E receptor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0051300:Receptor, Apolipoprotein E [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416912:APOLIPOPROTEIN E RECEPTOR [Gene or Genome]
           APOLIPOPROTEIN RECEPTOR
  1000   C2987172:Apolipoprotein E Receptor [Amino Acid, Peptide, or Protein]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.245: Neurology, 49, 56-61. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "49,"

Phrase: "56-61."
Processing 00000000.tx.246: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.247: Hollenbach,E., Ackermann,S., Hyman,B.T. and Rebeck,G.W. 

Phrase: "Hollenbach,"

Phrase: "E.,"

Phrase: "Ackermann,"

Phrase: "S."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "and"

Phrase: "Rebeck,"

Phrase: "G.W."
Processing 00000000.tx.248: (1998) Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Confirmation of an association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   770   C0750484:Confirmation [Idea or Concept]

Phrase: "between a polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in exon 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the low-density lipoprotein receptor-related protein gene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   927   C1366529:Low density lipoprotein receptor gene [Gene or Genome]
           LOW DENSITY LIPOPROTEIN RECEPTOR
   845   C1335671:Receptor Gene [Gene or Genome]
   818   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0017337:Gene [Gene or Genome]
   710   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   710   C0242972:low protein [Therapeutic or Preventive Procedure]
   710   C0748025:low protein [Finding]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.249: Neurology, 50, 1905-1907. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "50,"

Phrase: "1905-1907."
Processing 00000000.tx.250: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.251: Pericak-Vance,M.A., Bass,M.P., Yamaoka,L.H., Gaskell,P.C., Scott,W.K., Terwedow,H.A., Menold,M.M., Conneally,P.M., Small,G.W., Vance,J.M., Saunders,A.M., Roses,A.D. and Haines,J.L. 

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yamaoka,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Terwedow,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Menold,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Vance,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "Haines,"

Phrase: "J.L."
Processing 00000000.tx.252: (1997) Complete genomic screen in late-onset familial Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "genomic screen in late-onset familial Alzheimer disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0220908:screen [Health Care Activity]
   744   C1305399:screen [Functional Concept]
   744   C1705053:Screen [Medical Device]
   703   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
Processing 00000000.tx.253: Evidence for a new locus on chromosome 12. 

Phrase: "Evidence for a new locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.254: J. 

Phrase: "J."
Processing 00000000.tx.255: Am. 

Phrase: "Am."
Processing 00000000.tx.256: Med. 

Phrase: "Med."
Processing 00000000.tx.257: Assoc., 278, 1237-1241. 

Phrase: "Assoc.,"

Phrase: "278,"

Phrase: "1237-1241."
Processing 00000000.tx.258: 20. 

Phrase: "20."
Processing 00000000.tx.259: Blacker,D., Wilcox,M., Laird,N., Rodes,L., Horvath,S., Go,R., Perry,R., Watson Jr,B., Bassett,S., McInnis,M., Albert,M., Hyman,B.T. and Tanzi,R. 

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."

Phrase: ","

Phrase: "Laird,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Horvath,"

Phrase: "S."

Phrase: ","

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Watson Jr,B.,"

Phrase: "Bassett,"

Phrase: "S."

Phrase: ","

Phrase: "McInnis,"

Phrase: "M."

Phrase: ","

Phrase: "Albert,"

Phrase: "M."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.260: (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "genetically"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.261: Nature Genet., 19, 357-360. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "19,"

Phrase: "357-360."
Processing 00000000.tx.262: MEDLINE Abstract 21. 

Phrase: "MEDLINE Abstract 21."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.263: Blacker,D., Haines,J.L., Rodes,L., Terwedow,H., Go,R.C., Harrell,L.E., Perry,R.T., Bassett,S.S., Chase,G., Meyers,D., Albert,M.S. and Tanzi,R. 

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J.L., Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Terwedow,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C., Harrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "L.E.,"

Phrase: "Perry,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bassett,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Chase,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Meyers,"

Phrase: "D."

Phrase: ","

Phrase: "Albert,"

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.264: (1997) ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. 

Phrase: "(1997"

Phrase: ")"

Phrase: "ApoE-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "age at onset of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]

Phrase: ":"

Phrase: "the NIMH genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "initiative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424093:Initiative [Mental Process]
Processing 00000000.tx.265: Neurology, 48, 139-147. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "48,"

Phrase: "139-147."
Processing 00000000.tx.266: MEDLINE Abstract *To whom correspondence should be addressed. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.267: Tel: +1 617 726 2299; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 617 726 2299"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.268: Fax: +1 617 726 5677; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 617 726 5677"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.269: Email: b_hyman@helix.mgh.harvard.edu This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk Last modification: 12 Nov 1998 CopyrightOxford University Press, 1998.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "b_hyman@helix.mgh.harvard.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "www-admin{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "12 Nov 1998 CopyrightOxford University Press,"

Phrase: "1998."

